InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,811.83
(
-2.55%
)
Post# of 252501
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: hptaxis post# 159402

Saturday, 04/06/2013 6:39:42 PM

Saturday, April 06, 2013 6:39:42 PM

Post# of 252501

Hence, the clinical study was initiated, and while at first it was slow to recruit, it ultimately was completed and viewed as strikingly successful. The drug – now in phase 3, and called ibrutinib — is not a magic bullet, but may emerge as a promising option for some patients with some B-cell cancers.



HUH? I don't think there is anything more magical in oncology right now.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up